IDEAYA Biosciences (NASDAQ: IDYA) reported Q4 EPS of ($0.52), $0.05 worse than the analyst estimate of ($0.47). Revenue for the quarter came in at $3.9 million versus the consensus estimate of $8.84 million.

For earnings history and earnings-related data on IDEAYA Biosciences (IDYA) click here.